Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

CDH16 and thyroid cancer are reported together in 1 article.

Gene

CDH16

HGNC
HGNC:1755
3articles
3mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
216articles
216mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

Loss of CDH16 expression is a strong independent predictor for lymph node metastasis in Middle Eastern papillary thyroid cancer.

PMID 37899424 | PMCID PMC10613612 | DOI 10.1038/s41598-023-45882-x · Scientific reports · 2023 · 4 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneCDH16“Loss of CDH16 expression is a strong independent predictor for lymph node metastasis in Middle Eastern papillary thyroid cancer.”0.98hgnc_dict_v1
phenotypethyroid cancer“Loss of CDH16 expression is a strong independent predictor for lymph node metastasis in Middle Eastern papillary thyroid cancer.”0.98phenotype_alias_lexicon_v2
geneBRAF“We also conducted BRAF and TERT mutations analyses through Sanger sequencing.”0.98hgnc_dict_v1
geneTERT“We also conducted BRAF and TERT mutations analyses through Sanger sequencing.”0.98hgnc_dict_v1